Novo Nordisk to launch GLP-1 injectible diabetes drug in tablet form by February

The oral medication is being seen as a breakthrough technology that could change the approach and acceptance of the drug for patients in India, which today has the dubious distinction of being the diabetes capital of the world.

Source link

Leave a Comment

Your email address will not be published.